Ignite Creation Date:
2024-05-06 @ 2:59 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04483882
Status:
COMPLETED
Last Update Posted:
2021-12-23
First Post:
2020-07-20
Brief Title:
Tactile Low Vision Labeling of Ophthalmic Drops
Sponsor:
The University of Texas Medical Branch Galveston
Organization:
The University of Texas Medical Branch Galveston
Study Overview
Official Title:
Utility and Efficacy of Tactile Labeling of Ophthalmic Drops for Identity and Frequency of Administration in Low Vision
Status:
COMPLETED
Status Verified Date:
2021-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch UTMB in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency with which they should be administered The labeling strategy includes protrusions as frequency markers and shapes to differentiate between treatments of similar frequency prescription
Detailed Description:
The purpose of this study is an evaluation of a tactile labeling strategy developed in the Ophthalmology Clinical Research Center at University of Texas Medical Branch UTMB in collaboration with the UTMB Maker Space to improve low vision patients capability to identify their topical ophthalmic drop treatments and the frequency with which they should be administered The labeling strategy includes protrusions as frequency markers and shapes to differentiate between treatments of similar frequency prescription
The first aim is to evaluate the patient capability to identify the number of protrusions and therefore the frequency of administration prescribed This should be completed in a timeframe that is not frustrating or problematic to the patient in practice
The second aim is to evaluate the patient ability to differentiate between drugs with similar frequencies based on a shape on the frequency protrusions in a tactile manner This also should be completed in a timeframe that is not over burdensome or frustrating to the patient The protocol is designed to evaluate this tactile labeling design in the population it is designed to support
The first aim is to evaluate the patient capability to identify the number of protrusions and therefore the frequency of administration prescribed This should be completed in a timeframe that is not frustrating or problematic to the patient in practice
The second aim is to evaluate the patient ability to differentiate between drugs with similar frequencies based on a shape on the frequency protrusions in a tactile manner This also should be completed in a timeframe that is not over burdensome or frustrating to the patient The protocol is designed to evaluate this tactile labeling design in the population it is designed to support
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None